Diabetic cardiomyopathy (DCM) mainly refers to myocardial metabolic dysfunction caused
by high glucose, and hyperglycemia is an independent risk factor for cardiac function in the …

Heart failure (HF) with preserved ejection fraction (HFpEF) is currently a preeminent
challenge for cardiovascular medicine. It has a poor prognosis, increasing mortality, and is …

Diabetic cardiomyopathy describes decreased myocardial function in diabetic patients in the
absence of other heart diseases such as myocardial ischemia and hypertension. Recent …

Diabetic cardiomyopathy (DCM), an important complication of diabetes mellitus (DM), is one
of the most serious chronic heart diseases and has become a major cause of heart failure …

Metabolic homeostasis balances the production and consumption of energetic molecules to
maintain active, healthy cells. Cellular stress, which disrupts metabolism and leads to the …

Ginsenoside Rg1 is the active ingredient of the plant named genus Panax (ginseng), which
exhibited significant bioactivities, including anti‐inflammatory, antioxidation, and anti …

Diabetic cardiomyopathy (DbCM) is a common complication in individuals with type 2
diabetes mellitus (T2DM), and its exact pathogenesis is still debated. It was hypothesized …

Heart failure (HF) caused by structural or functional cardiac abnormalities is a significant
cause of morbidity and mortality worldwide. While HF with reduced ejection fraction (HErEF) …

Diabetic kidney disease (DKD) is a global health issue that presents a complex
pathogenesis and limited treatment options. To provide guidance for precise therapies, it is …

Endurance exercise training is a promising cardioprotective strategy in type 2 diabetes
mellitus (T2DM), but the impact of its intensity is not clear. We aimed to investigate whether …